Salesforce announced on Aug. 26, 2025, that more than 70 companies, including pharmaceutical and medical-device players and CROs, have selected its Life Sciences Cloud to unify clinical, commercial and patient-services data. Customers include Pfizer, Takeda, Fresenius Kabi, Boehringer Ingelheim and Penumbra. Salesforce describes the platform as an end-to-end engagement system that brings together sales, service,… The post Salesforce’s Life Sciences Cloud signals an inflection point for dr...| Research & Development World
Scalability is a common issue facing pharma leaders who have deployed Generative AI (GenAI) applications as a proof of concept (PoC). Many are dazzled by their promise of streamlining staid work processes. Agentic AI and other new GenAI technologies can make PoCs faster and easier to launch, advancing scalability as well as security and development… The post Scaling pharma AI PoCs to enterprise deployments: Blending new tech with old-school rigor appeared first on Drug Discovery and Develop...| Drug Discovery and Development